Items where authors include "Murden, G."

Article

Higginson, I.J., Brown, S.T., Oluyase, A.O. et al. (24 more authors) (2024) Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial. The Lancet Respiratory Medicine, 12 (10). pp. 763-774. ISSN 2213-2600

Walker, K. orcid.org/0000-0001-6922-9100, Hinsley, S., Phillip, R. orcid.org/0000-0002-9604-9276 et al. (6 more authors) (2022) Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations—CONCORDE. JCO Precision Oncology, 6 (6). e2200133. ISSN 2473-4284

Krajnik, M., Hepgul, N., Wilcock, A. et al. (59 more authors) (2022) Do guidelines influence breathlessness management in advanced lung diseases? A multinational survey of respiratory medicine and palliative care physicians. BMC Pulmonary Medicine, 22. 41. ISSN 1471-2466

Conference or Workshop Item

Schofield, H. orcid.org/0000-0001-8564-7038, Bowen, A., Day, F. et al. (6 more authors) (2024) How do we make trials more inclusive of people with complex needs after stroke? In: International Clinical Trials Methodology Conference (ICTMC 2024), 30 Sep 2024, Edinburgh, UK.

Schofield, H. orcid.org/0000-0001-8564-7038, Moreau, L., Muir, D. et al. (8 more authors) (2024) Involving stroke survivors and families in developing a platform trial for life after stroke. In: European Life After Stroke Forum, 11-12 Mar 2024, Dublin.